Wilson Sonsini Goodrich & Rosati advised Recursion Pharmaceuticals, Inc.; and Davis Polk & Wardwell LLP advised Jefferies LLC, as sales agent, in the offering. Recursion Pharmaceuticals,...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell advised Upgrade, Inc. on the transaction. Upgrade, Inc. announced the acquisition of Uplift, Inc., the leading provider of Buy Now Pay Later (BNPL)...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP advised IDEAYA Biosciences, Inc., while Davis Polk & Wardwell LLP advised Jefferies LLC in the offering. IDEAYA Biosciences, Inc. announced the SEC-registered at-the-market...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Coherus BioSciences, and Davis Polk advised J.P. Morgan Securities LLC and Citigroup Global Markets Inc. on the offering. Coherus BioSciences, Inc. (“Coherus”, Nasdaq:...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the initial purchasers in the offering and also advised the counterparties on capped call transactions. Bloom Energy Corporation (NYSE: BE)...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the underwriter on the transaction. Mirion Technologies announced the $52.9 million offering of 7,000,000 shares of Class A common stock of Mirion Technologies,...
You must be a Standard 1 Year member to access this content.
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Fenwick advised DexCom on the offering, while Davis Polk advised the representatives of the initial purchasers and the counterparties to the capped call transactions. DexCom, Inc....
You must be a Standard 1 Year member to access this content.
K&L Gates advised AVITA, and Davis Polk advised the sales agent for the offering. AVITA Medical, Inc. announced the establishment of an SEC-registered at-the-market program of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Equinix Inc. on the offering. Equinix, Inc. announced the private placement of ¥77.28 billion aggregate principal amount of senior notes by its wholly...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Mirion Technologies on the offering, and Davis Polk advised the underwriter. Mirion Technologies announced the $85.6 million offering of 9,786,153 shares of its Class...
You must be a Standard 1 Year member to access this content.
Latham & Watkins is advising Revolution Medicines on the offering, and Davis Polk is advising the underwriters involved. Revolution Medicines, Inc. (Nasdaq: RVMD) has announced the...
You must be a Standard 1 Year member to access this content.
